Read our blog

What we have to say about tech and biotech...
tax is more exciting than you might think!

Latest posts

Autumn Statement 2014

By colinhailey | December 4, 2014

3 December 2014 The major changes relevant to technology and biotechnology companies announced in the Autumn Statement are set out below. We will get further details…

Confluence Tax assists F-star Alpha on asset centric deal with Bristol-Myers Squibb

By colinhailey | November 3, 2014

          Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy

Budget 2014

By colinhailey | March 20, 2014

Overview The intention to rebalance the economy and encourage investment has resulted in a budget for 2014 which provides targeted rewards for certain activities. The likely…

Colin Hailey talks to Pharma TV about UK R&D tax credits

By colinhailey | January 7, 2014

Budget 2013

By colinhailey | March 21, 2013

Overview There were few changes specifically relevant to technology and biotechnology companies announced in the 2013 Budget. Many measures are now announced as intentions for future…